Relationship between Erectile Dysfunction and Asymmetric Dimethyl Arginine Levels in Patients with End-Stage Renal Disease
Open Access
- 30 June 2025
- journal article
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (2) , 133-139
Abstract
Introduction: Asymmetric dimethylarginine is a major inhibitor of nitric oxide synthesis. Erectile dysfunction and chronic kidney disease (CKD) are associated with elevated levels of asymmetric dimethylarginine. This study aimed to examine the effects of ADMA on erectile dysfunction in patients undergoing peritoneal hemodialysis. Methods: A total of 32 peritoneal, 32 hemodialysis patients, and 32 healthy male volunteers were included in the study. Serum asymmetric dimethylarginine levels were measured, and clinical and laboratory parameters were analyzed. The International Index of Erectile Function-5 was used to evaluate sexual function and the Pittsburgh Sleep Quality Index was used to evaluate sleep quality. Depressive symptoms were assessed using the Beck Depression Inventory Scale. Results: Asymmetric dimethylarginine levels differed significantly among the three groups (pKeywords
This publication has 37 references indexed in Scilit:
- Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective studyNutrition, Metabolism and Cardiovascular Diseases, 2024
- Residual Kidney Function and Cause-Specific Mortality Among Incident Hemodialysis PatientsKidney International Reports, 2023
- Does mean platelet volume (MPV) have a role in evaluation of erectile dysfunction and its severity?Revista Internacional de Andrología, 2020
- Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With ParicalcitolKidney International Reports, 2017
- Sexual dysfunction in chronic renal failureJournal of Men's Health, 2011
- The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratioPharmacology & Therapeutics, 2007
- Sexual dysfunction in male patients on hemodialysis: assessment with the International Index of Erectile Function (IIEF)International Journal Of Impotence Research, 2002
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyThe Lancet, 2001
- Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatmentAmerican Journal of Kidney Diseases, 1997
- Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between FacilitiesAmerican Journal of Kidney Diseases, 1990